Open Government Portal

Open Data Portal Catalogue Dataset
Found 40380 records

Health Canada has completed a safety review on the potential risk of BIA-ALCL, following an increase in the number of …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Breast Implants assessing potential-risk of cancer Breast-implant associated-anaplastic large-cell-lymphoma BIA-ALCL

Health Canada carried out a safety review of all the available evidence to evaluate the risk of side effects related …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Celecoxib safety review assessing heart-and-stroke side effects high doses Non-Steroidal Anti-Inflammatory Drugs NSAIDs diclofenac ibuprofen naproxen

Clozapine is a prescription drug authorized for sale in Canada to manage symptoms of schizophrenia when other drugs have not …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Clozapine assessing effectiveness monitoring white-blood-cells levels low-numbers of white-blood-cells agranulocytosis symptoms of schizophrenia life-threatening infections-and-deaths patient registry program

Codeine is converted to morphine in the liver. Some people have genetic variations of liver enzymes which cause codeine to …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review CODEINE assessing breathing problems children and adolescents liver liver enzymes genetic differences ultra-rapid metabolizers

In 2013 and 2015, Health Canada carried out safety reviews on codeine-containing products as they relate to the risk of …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Codeine-containing products assessing serious breathing problems Children and Adolescents treated with codeine

A safety review was carried out after Health Canada received a report from the European Medicines Agency, which linked hearing …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Denosumab Prolia Xgeva hearing loss deafness

Diclectin is a drug authorized in Canada to treat nausea and vomiting in pregnancy (i.e. morning sickness). The safety of …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review DICLECTIN doxylamine and pyridoxine assessing safety in pregnancy nausea vomiting pregnancy morning sickness

A safety review was carried out by Health Canada to evaluate the increased risk of heart failure with the use …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Dipeptidylpeptidase-4 DPP-4 Inhibitors assessing risk heart failure saxagliptin alogliptin other risk factors

Health Canada reviewed the risk of IR thermometers being inaccurate when checking the temperature of children under 2 years old …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review ear forehead Infrared Thermometers IR thermometers assessing potential-risk of inaccuracy children under 2-years-old

Health Canada carried out a safety review due to concerns regarding complications associated with the Essure device after it is …

Last Updated: May 6, 2024
Date Published: May 6, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review ESSURE Permanent Birth-Control-System Essure device removed fallopian tubes assessing risk of complications potential need-for Device-Removal surgical intervention removal of the uterus hysterectomy